Volume 98, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



With an unprecedented number of displaced persons worldwide, strategies for improving the health of migrating populations are critical. United States–bound refugees undergo a required overseas medical examination to identify inadmissible conditions (e.g., tuberculosis) 2–6 months before resettlement, but it is limited in scope and may miss important, preventable infectious, chronic, or nutritional causes of morbidity. We sought to evaluate the feasibility and health impact of diagnosis and management of such conditions before travel. We offered voluntary testing for intestinal parasites, anemia, and hepatitis B virus infection, to U.S.-bound refugees from three Thailand–Burma border camps. Treatment and preventive measures (e.g., anemia and parasite treatment, vaccination) were initiated before resettlement. United States refugee health partners received overseas results and provided post-arrival medical examination findings. During July 9, 2012 to November 29, 2013, 2,004 refugees aged 0.5–89 years enrolled. Among 463 participants screened for seven intestinal parasites overseas and after arrival, helminthic infections decreased from 67% to 12%. Among 118 with positive -specific antibody responses, the median fluorescent intensity decreased by an average of 81% after treatment. The prevalence of moderate-to-severe anemia (hemoglobin < 10 g/dL) was halved from 14% at baseline to 7% at departure (McNemar = 0.001). All 191 (10%) hepatitis B–infected participants received counseling and evaluation; uninfected participants were offered vaccination. This evaluation demonstrates that targeted screening, treatment, and prevention services can be conducted during the migration process to improve the health of refugees before resettlement. With more than 250 million migrants globally, this model may offer insights into healthier migration strategies.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. United Nations High Commissioner for Refugees (UNHCR), 2015. Global Trends: Figures at a Glance. Available at: http://www.unhcr.org/figures-at-a-glance.html. Accessed August 15, 2016.
  2. U.S. Department of State Bureau of Population, Refugees, and Migration; , 2016. Refugee Admissions Report. Available at: http://www.wrapsnet.org/admissions-and-arrivals/. Accessed February 1, 2017.
  3. Centers for Disease Control and Prevention (CDC), 2014. Laws and Regulations. Available at: https://www.cdc.gov/immigrantrefugeehealth/laws-regulations.html. Accessed April 19, 2017.
  4. Centers for Disease Control and Prevention (CDC), 2014. Refugee Health Guidelines. Available at: http://www.cdc.gov/immigrantrefugeehealth/guidelines/refugee-guidelines.html. Accessed July 11, 2016.
  5. Maskery B, Coleman MS, Weinberg M, Zhou W, Rotz L, Klosovsky A, Cantey PT, Fox LM, Cetron MS, Stauffer WM, , 2016. Economic analysis of the impact of overseas and domestic treatment and screening options for intestinal helminth infection among US-bound refugees from Asia. PLoS Negl Trop Dis 10: e004910.
  6. Weinbaum CM, Mast EE, Ward JW, , 2009. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology 49: S35S44.
  7. Centers for Disease Control and Prevention (CDC), 2014. Guidelines for Overseas Presumptive Treatment of Strongyloidiasis, Schistosomiasis, and Soil-Transmitted Helminth Infections. Available at: http://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/intestinal-parasites-overseas.html. Accessed July 11, 2016.
  8. Centers for Disease Control and Prevention (CDC), 2013. Domestic Intestinal Parasite Guidelines. Available at: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/intestinal-parasites-domestic.html. Accessed July 11, 2016.
  9. Kling PJ, Schmidt RL, Roberts RA, Widness JA, , 1996. Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr 128: 791796.
  10. Priest JW, ., 2016. Integration of multiplex bead assays for parasitic diseases into a national, population-based serosurvey of women 15–39 years of age in Cambodia. PLoS Negl Trop Dis 10: e0004699.
  11. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y, , 1994. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis 18: 1923.
  12. Easton AV, ., 2016. Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming. Parasit Vectors 9: 38.
  13. Sissoko MS, ., 2017. Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis 17: 498509.
  14. World Health Organization, 2016. Application Tools. Available at: http://www.who.int/growthref/tools/en/. Accessed July 11, 2016.
  15. Averhoff F, , 2017. Hepatitis B. CDC Health Information for International Travel 2018. Centers for Disease Control and Prevention. New York, NY: Oxford University Press, 187193.
  16. Vryheid RE, Yu ES, Mehta KM, McGhee J, , 2001. The declining prevalence of hepatitis B virus infection among Asian and Pacific Islander children. Asian Am Pac Isl J Health 9: 162178.
  17. Yun K, ., 2016. Increasing hepatitis B vaccine prevalence among refugee children arriving in the United States, 2006–2012. Am J Public Health 106: 14601462.
  18. Centers for Disease Control and Prevention (CDC), 2016. Vaccination Program for U.S.-Bound Refugees. Available at: https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/interventions/immunizations-schedules.html. Accessed February 1, 2017.
  19. Rossi C, Schwartzman K, Oxlade O, Klein MB, Greenaway C, , 2013. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis. PLoS One 8: e78548.
  20. Jazwa A, Coleman MS, Gazmararian J, Wingate LT, Maskery B, Mitchell T, Weinberg M, , 2015. Cost-benefit comparison of two proposed overseas programs for reducing chronic hepatitis B infection among refugees: is screening essential? Vaccine 33: 13931399.
  21. Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA, , 2011. The increasing burden of imported chronic hepatitis B—United States, 1974–2008. PLoS One 6: e27717.
  22. Mejia R, Nutman T, , 2012. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25: 458463.
  23. Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Paterson BR, Walker PF, , 2005. Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 128: 36813684.
  24. Anderson NW, Klein DM, Dornink SM, Jespersen DJ, Kubofcik J, Nutman TB, Merrigan SD, Couturier MR, Theel ES, , 2014. Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis. Clin Vaccine Immunol 21: 732736.
  25. Requena-Méndez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo E, Muñoz J, , 2013. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis 7: e2002.
  26. Naidu P, Yanow SK, Kowalewska-Grochowska KT, , 2013. Eosinophilia: a poor predictor of Strongyloides infection in refugees. Can J Infect Dis Med Microbiol 24: 9396.
  27. Hays R, Thompson F, Esterman A, McDermott R, , 2016. Strongyloides stercoralis, eosinophilia, and type 2 diabetes mellitus: the predictive value of eosinophilia in the diagnosis of S. stercoralis infection in an endemic community. Open Forum Infect Dis 3: ofw029.
  28. Speare R, Durrheim D, , 2004. Mass treatment with ivermectin: an underutilized public health strategy. Bull World Health Organ 82: 562.
  29. Muennig P, Pallin D, Sell RL, Chan MS, , 1999. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 340: 773779.
  30. Einarsson E, Ma’ayeh S, Svard SG, , 2016. An up-date on Giardia and giardiasis. Curr Opin Microbiol 34: 4752.
  31. Heimer J, Staudacher O, Steiner F, Kayonga Y, Havugimana JM, Musemakweri A, Harms G, Gahutu JB, Mockenhaupt FP, , 2015. Age-dependent decline and association with stunting of Giardia duodenalis infection among schoolchildren in rural Huye district, Rwanda. Acta Trop 145: 1722.
  32. World Health Organization (WHO), 2016. Daily Iron Supplementation in Infants and Children. Available at: http://www.who.int/nutrition/publications/micronutrients/guidelines/daily_iron_supp_childrens/en/. Accessed July 28, 2017.
  33. Neuberger A, Okebe J, Yahav D, Paul M, , 2016. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev 2: CD006589.
  34. The Border Consortium, 2016. Annual Report, January–December 2015. Available at: http://www.theborderconsortium.org/media/67600/2015-Annual-Report-Jan-Dec.pdf. Accessed July 13, 2016.
  35. Mitchell T, Jentes E, Ortega L, Scalia Sucosky M, Jefferies T, Bajcevic P, Parr V, Jones W, Brown MJ, Painter J, , 2012. Lead poisoning in United States-bound refugee children: Thailand–Burma border, 2009. Pediatrics 129: e392e399.
  36. Sphere Project, 2011. Sphere Handbook: Humanitarian Charter and Minimum Standards in Disaster Response. Available at: http://www.refworld.org/docid/4ed8ae592.html. Accessed October 13, 2017.

Data & Media loading...

Supplementary Data

Supplemental Figure and Table

  • Received : 15 Sep 2017
  • Accepted : 19 Oct 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error